SCHEMBL7909692

SCHEMBL7909692

CC(C)(C)OC(=O)N1C=CCN(C(=O)OC(C)(C)C)C1

nearest known ligand 0.42

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
PREP P48147 1/20 0.41
ESR2 Q92731 1/20 0.38
NR1H2 P55055 3/20 0.38
GRM5 P41594 1/20 0.37
HPGD P15428 1/20 0.36
GPR119 Q8TDV5 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
PDK4 Q16654 1/20 0.35
RECQL P46063 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL222920 0.79 PREP (0.53) USP2SMN1; SMN2PREPESR2NR1H2
SCHEMBL1601359 0.73 USP2 (0.42) USP2SMN1; SMN2PREPESR2NR1H2
SCHEMBL1838102 0.71 PREP (0.37) USP2SMN1; SMN2PREPESR2NR1H2
SCHEMBL173435 0.71 USP2 (0.49) USP2SMN1; SMN2PREPESR2HPGD
SCHEMBL1242684 0.71 USP2 (0.52) USP2SMN1; SMN2PREPESR2NR1H2
SCHEMBL2496477 0.71 USP2 (0.52) USP2SMN1; SMN2PREPESR2NR1H2
Hydrochloric Acid SCHEMBL28241841 0.70 PREP (0.36) USP2SMN1; SMN2PREPESR2NR1H2
SCHEMBL2600436 0.70 USP2 (0.40) USP2SMN1; SMN2PREPESR2NR1H2
SCHEMBL28856336 0.70 CHRM2 (0.38) USP2SMN1; SMN2PREPESR2NR1H2
SCHEMBL4693378 0.69 HPGD (0.46) USP2SMN1; SMN2PREPESR2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6211184-B1 TETRAHYDRO-PYRAZINE OR PYRIMIDINE DERIVATIVES; VITRONECTIN RECEPTOR ANTAGONIST; OSTEOPOROSIS; ANTIINFLAMMATORY, ANTITUMOR AGENTS; ANGIOGENESIS AND RESTENOSIS INHIBITORS MERCK & CO., INC. 2001-04-03 US disclosed
US-5981546-A Integrin antagonists MERCK & CO., INC. (US) 1999-11-09 US disclosed